The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Vir Biotechnology, Inc(NASDAQ:VIR) 
Vir Biotechnology, Inc., a clinical-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 for the prevention of influenza A virus; VIR-1111 for the prevention of hum...
Website: http://www.vir.bio
Founded: 2016
IPO Price: $20 (Oct 11, 2019)
Full Time Employees: 297
CEO: George A. Scangos
Sector: Healthcare
Industry: Biotechnology
Vir Biotechnology Days Payable Outstanding ttm (DPO)
Vir Biotechnology Days Receivable Outstanding ttm (DSO)
Vir Biotechnology Op Cashflow Per Share ttm
Vir Biotechnology Free Cashflow Per Share ttm
Vir Biotechnology Cash Per Share ttm
Vir Biotechnology P/S ratio ttm
Vir Biotechnology (GAAP) P/E ratio ttm
Vir Biotechnology P/B ratio ttm
No extra charts and metrics for this ticker.